Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
15.65
-0.12 (-0.76%)
Mar 20, 2026, 2:50 PM EDT - Market open

TNXP Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-124.02-130.04-116.66-110.22-92.29
Depreciation & Amortization
1.933.424.291.250.05
Stock-Based Compensation
6.024.789.2810.917.9
Other Adjustments
5.8555.141.12-3
Change in Receivables
-2.62-3.68---
Changes in Inventories
1.733.740.06--
Changes in Accounts Payable
2.990.93-3.49-1.053.53
Changes in Accrued Expenses
11.751.191.791.211.75
Changes in Other Operating Activities
-3.463.61.61-0.160.51
Operating Cash Flow
-99.84-60.93-102-98.05-75.56
Capital Expenditures
-3.37-0.12-7.9-48.15-35.31
Sale of Property, Plant & Equipment
--1--
Payments for Business Acquisitions
---22.17--
Other Investing Activities
-1.16----
Investing Cash Flow
-4.53-0.12-29.07-48.15-35.31
Long-Term Debt Issued
--8.94--
Long-Term Debt Repaid
-9.65-2.35---
Net Long-Term Debt Issued (Repaid)
-9.65-2.358.94--
Issuance of Common Stock
237.94140.2241.5494.5212.49
Repurchase of Common Stock
-13.76--13.97--
Net Common Stock Issued (Repurchased)
224.18140.2227.5894.5212.49
Issuance of Preferred Stock
---40.59-
Repurchase of Preferred Stock
----47.25-
Net Preferred Stock Issued (Repurchased)
----6.66-
Other Financing Activities
--3---
Financing Cash Flow
214.53134.8736.5287.84212.49
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.030-0.07-0.07-0.03
Net Cash Flow
110.1373.83-94.62-58.43101.59
Free Cash Flow
-103.21-61.05-109.9-146.2-110.86
FCF Margin
-787.46%-604.77%-1414.75%--
Free Cash Flow Per Share
-12.13-82.90-13867.26-80089.74-194715.03
Levered Free Cash Flow
-122.11-119.63-111.36-163.77-121.76
Unlevered Free Cash Flow
-114.15-123.94-122.02-158.99-121.79
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q